J. Peter Rubin, MD
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, J. Peter Rubin, MD sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
J. Peter Rubin, MD: 4 sponsored US clinical trials, none currently recruiting.
J. Peter Rubin, MD sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Limb Shortening, with 1 trials.
Upper-quartile sponsor footprint
J. Peter Rubin, MD sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Superficial Partial-Thickness Burn Study
NCT04601532
Enhanced Bioscaffold for Volumetric Muscle Loss
NCT04051242
AMP30: Autologous Fat Grafting, Amputation Sites Pain: Randomized
NCT02076022
Effect of Concentrating Endogenous Stromal Cells in the Fat Graft Using TGI Device
NCT01924364
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
How the J. Peter Rubin, MD archive is shaped
4 indexed studies, none listed as recruiting (0% open); 2 completed (50%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Limb Shortening (1 trial), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
J. Peter Rubin, MD: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
J. Peter Rubin, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this J. Peter Rubin, MD page
4 registered trials is a research-attention snapshot, not an endorsement of J. Peter Rubin, MD or any single study.
- None of J. Peter Rubin, MD's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Limb Shortening is the condition J. Peter Rubin, MD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Limb Shortening trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. J. Peter Rubin, MD pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.